Among the different possible alternative protein sources, a microbial protein (MP) obtained from bacteria, fungi (filamentous fungi and yeast), and microalgae, represents a highly efficient and potentially abundant protein source for both animal and human nutrition. The present chapter overviews and discusses the main aspects of MP production from various microorganisms, including their positioning in the nascent and fast-growing alternative protein industry. The chapter further explores and discusses the possibilities offered by the MP platform in relation to the nascent circular bioeconomy framework, particularly in relation to the European context. Finally, the main issues and obstacles that must be faced and overcome to bring MP to comm...
Introduction. Les microalgues peuvent être considérées comme une des sources fiables de nutriments e...
Microalgae express high protein levels and can be produced in contained cultivation systems with low...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
Microbial biotechnology has a long history of producing feeds and foods. The key feature of today's ...
In the modern world, animal and plant protein may not meet the sustainability criteria due to their ...
Microbial biotechnology has a long history of producing feeds and foods. The key feature of today's ...
The growing global population and higher living standards instantly demand the transition in the dir...
It is estimated that the world will need an extra 265 million tons of protein by the middle of this ...
Most of the hosts used to produce the 151 recombinant pharmaceuticals so far approved for human use ...
This research paper investigates the potential of Mycoprotein as a sustainable alternative protein s...
Microbial protein (MP) – the biomass of bacteria, yeasts, filamentous fungi and microalgae – is an a...
Securing a sustainable protein supply at the global level is among the greatest challenges currently...
Microbial proteins, i.e., single-cell proteins or microbial biomass, can be cultivated for food and ...
The increased pressure over soils imposed by the need for agricultural expansion and food production...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
Introduction. Les microalgues peuvent être considérées comme une des sources fiables de nutriments e...
Microalgae express high protein levels and can be produced in contained cultivation systems with low...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
Microbial biotechnology has a long history of producing feeds and foods. The key feature of today's ...
In the modern world, animal and plant protein may not meet the sustainability criteria due to their ...
Microbial biotechnology has a long history of producing feeds and foods. The key feature of today's ...
The growing global population and higher living standards instantly demand the transition in the dir...
It is estimated that the world will need an extra 265 million tons of protein by the middle of this ...
Most of the hosts used to produce the 151 recombinant pharmaceuticals so far approved for human use ...
This research paper investigates the potential of Mycoprotein as a sustainable alternative protein s...
Microbial protein (MP) – the biomass of bacteria, yeasts, filamentous fungi and microalgae – is an a...
Securing a sustainable protein supply at the global level is among the greatest challenges currently...
Microbial proteins, i.e., single-cell proteins or microbial biomass, can be cultivated for food and ...
The increased pressure over soils imposed by the need for agricultural expansion and food production...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...
Introduction. Les microalgues peuvent être considérées comme une des sources fiables de nutriments e...
Microalgae express high protein levels and can be produced in contained cultivation systems with low...
Both conventional and innovative biomedical approaches require cost-effective protein drugs with hig...